All Stories

  1. State of the art and trends of circulating cancer biomarkers

    Article • The International Journal of Biological Markers, February 2020, SAGE Publications

    Massimo Gion

  2. Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, April 2019, Taylor & Francis

    Ruggero Dittadi, Massimo Gion

  3. Preanalytical stability of [-2]proPSA in whole blood stored at room temperature before separation of serum and plasma: implications to Phi determination

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), September 2018, De Gruyter

    Massimo Gion

  4. Epidemiology-Based Assessment of Tumor Marker Overordering in Breast Cancer: An Algorithm to Examine Different Disease Conditions

    Article • The International Journal of Biological Markers, October 2017, SAGE Publications

    Ruggero Dittadi, Massimo Gion

  5. Circulating Tumor Markers: A Guide to their Appropriate Clinical Use

    Article • The International Journal of Biological Markers, April 2017, SAGE Publications

    Massimo Gion

  6. Circulating Tumor Markers: A Guide to Their Appropriate Clinical Use: Comparative Summary of Recommendations from Clinical Practice Guidelines (PART 2)

    Article • The International Journal of Biological Markers, January 2017, SAGE Publications

    Massimo Gion